Coronavirus 2021 invites speakers to submit abstract on the following sessions but not limited to:
Viral Epidemiology | Submit
Viral epidemiology is the scientific discipline concerned with the study of the incidence and spread of viruses in populations over time. Host, virus and environmental factors are monitored to determine the dynamics of viral infections, the ultimate goal of which is to devise intervention strategies. The session includes virus transmission, mechanisms of survival of viruses in nature, emerging viral diseases, Epidemiological Characteristics of diseases.
Clinical Virology | Submit
Virology that pertains to virus-induced clinical conditions. It includes the study of resistance of viruses in treatment antiviral by viral genome sequencing, viral pathogenesis and viral immunology. The session includes topics like various cultures, serological, biochemical and molecular studies. This field is very useful in knowing the epidemiology and spreading of viral diseases.
Viral Pathogenesis | Submit
Pathogenesis is the process by which an infection leads to disease. The session includes mechanisms of the virus entry, replication, spread to target organs and spread to sites of shedding of virus into the environment.
Virus – host Interactions | Submit
Viruses display remarkable specificity in both the host species and the cell types that they infect. Understanding this specificity reveals insight into the basic host components that are required for the viral life cycle and host restriction factors that limit the virus. The sessions
Immune response to infection | Submit
The immune response is how the human body recognizes and defends itself against these respiratory viruses that appear foreign and harmful.
Symptoms & Transmission | Submit
Human to human transmission of coronaviruses is primarily thought to occur among close contacts via respiratory droplets generated by sneezing and coughing. There are lots of symptoms other than fever, cold, cough and some have reported without symptoms. People who have underlying medical conditions and those over 60 years old have a higher risk of developing severe disease and death.
Respiratory Tract Infections | Submit
The talks include Severe acute respiratory syndrome (SERS) and Middle East respiratory syndrome (MERS) and their treatment and cure.
Mechanisms of Virus Replication | Submit
The track describes the formation of viruses during the infection process in target host cells as viral replication. The discussions involve multiplication within the host cell, viral populations, penetration.
Clinical Infections | Submit
Coronavirus has a group of related viruses that causes the below infections. These topics will be discussed.
Nosocomial infections | Submit
Hospital-related infections have been widely reported during the ongoing coronavirus outbreak, with healthcare professionals bearing a disproportionate risk.
SARSr-CoV | Submit
SARS coronavirus (SARS-CoV) – virus identified in 2003. SARS-CoV is thought to be an animal virus from an as-yet-uncertain animal reservoir, perhaps bats, that spread to other animals (civet cats) and first infected humans in the Guangdong province of southern China in 2002. Their study, research and prevention will be discussed in this session.
MERS?CoV | Submit
Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a novel coronavirus (Middle East respiratory syndrome coronavirus, or MERS?CoV) that was first identified in Saudi Arabia. Their study, research and prevention will be discussed in this session.
Coronavirus disease 2019 (COVID-19) | Submit
The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing pandemic of coronavirus disease 2019 (COVID?19) which is caused by severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2). This track describes about the causes, signs, symptoms, physiology, prevention and management, global social and economic disruption.
Epidemic outbreak of Covid19 | Submit
In humans, coronaviruses cause respiratory tract infections that can range from mild (common cold) to lethal (SARS, MERS, and COVID-19) and recover without requiring special treatment and in birds and mammals also cause various diseases. People with medical problems like diabetes, chronic respiratory disease, cardiovascular disease, and cancer and also in elder are more likely to develop serious illness. At present, no specific treatment is there for disease caused by a novel coronavirus.
Infection Control | Submit
This track includes topics which discusses control measures to prevent the infections from basic sanitization to surveillance, monitoring, and investigating any suspected outbreak of infection. And also about prevention of spread of infections, isolation and quarantine. Infection control prevents nosocomial or healthcare-associated with infection, a practical (rather than academic) sub-discipline of epidemiology.
Infection control and Hospital epidemiology are related to the general public health practice. The infection management relevants to the spreading of infections, either within the hospitals or alternative aid centres, as well as difficulty via hand hygiene, cleansing or disinfection or sanitization, vaccines or surveillance and probe of infections in a health-care domain.
Anti-viral drugs & Vaccines | Submit
Drugs and vaccines used for the treatment of viral infections. The session includes virus life cycle, vaccinations (including policy and controversy), antiretroviral therapy, viral synthesis and new Drug repositioning research. The emergence of antimicrobial resistance poses a serious challenge to health care practitioners. Management and control of multidrug-resistant organisms should include good infection control practices, good antimicrobial stewardship programs and novel antimicrobials with new mechanisms of action.
Vaccine & Drug Development | Submit
This session discusses about the drug discovery, Screening and designing. It also includes new clinical trials for the treatment and prevention of emerging infections, testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this disease.
Treatment & Cure | Submit
Treatment of viral infections such involves patient care and moral support including antiretroviral therapy. This session includes management of infections, treatment and evaluation of patients.
Risk factors & Prevention | Submit
Risk factors play a central part in prediction and prevention. Some infections can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks.
Management of COVID19 | Submit
As the coronavirus pandemic rapidly sweeps across the globe, it is inducing a considerable degree of emotional changes like fear, worry and concern in the population at large groups such as older adults, care providers and people with underlying health conditions. The psychological impact has increased stress or anxiety in all age groups and also has impact on people’s usual activities, routines or livelihoods.
Epidemics and outbreaks | Submit
Emerging new viruses and related infections had a global impact terribly. The number of high-threat infectious hazards continues to rise and some of these are re-emerging and others are new. While outbreaks of vaccine-preventable infectious diseases can have disastrous effects in areas with limited health infrastructure and resources, and where timely detection and response is difficult.
Coronavirus Pneumonia | Submit
Most people who get COVID-19 have mild or moderate symptoms like coughing, a fever, and shortness of breath. But some who catch the new coronavirus get severe pneumonia in both lungs. COVID-19 pneumonia is a serious illness that can be deadly. This session discussed about the symptoms, prevention and cure.
Eradication of Coronavirus | Submit
Disease control is when we see a reduction in disease incidence and prevalence (new cases and current cases) as a result of public health measures. The reduction does not mean to zero cases, but rather to an acceptable level. For disease elimination, there must be zero new cases of the disease in a defined geographic area. There is no defined time period this needs to be sustained for – it usually depends on the incubation period of the disease (the time between being exposed to the virus and the onset of symptoms). Finally, disease eradication is when there are zero incidences worldwide of a disease following deliberate efforts to get rid of it. In this scenario, we no longer need intervention measures.
Submit your abstract here